BioSpace News Archive

Booth 421 next to the Health Innovation Pavilion

Concert Pharmaceuticals (NASDAQ: CNCE) today announced that it will participate at the following upcoming investor conferences:

Spectrum Pharmaceuticals today announced that an overview of the company’s business strategy and commercial and development-stage programs will be given at the Jefferies 2018 London Healthcare Conference being held in London.

Rocket Pharma (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, announces the clearance of the Company’s Investigational New Drug (IND) application for RP-L102, the Company’s lentiviral vector (LVV)-based gene therapy for the treatment of Fanconi Anemia (FA), by the U.S. Food and Drug Administration (FDA).

Acceleron Pharma Inc. today announced plans to deliver three preclinical presentations on sotatercept in Pulmonary Arterial Hypertension (PAH) at the 2018 American Heart Association (AHA) Scientific Session in Chicago, IL, November 10-12, 2018.

Charles River Laboratories International, Inc. today reported its results for the third quarter of 2018. For the quarter, revenue was $585.3 million, an increase of 26.1% from $464.2 million in the third quarter of 2017.

Fanconi Anemia (FA) Data Presented at ESGCT Shows Increasing and Durable Engraftment for up to 30 Months with First Generation Product

Exicure, Inc. announced today plans to attend two investor conferences and two scientific conferences in November 2018.

TIME-2b Clinical Trial of AKB-9778 in Patients with Diabetic Retinopathy On Track

PROCEPT BioRobotics today announced the appointment of Kevin Waters as chief financial officer.